Chile Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence on Chile's Pharmaceuticals and Healthcare Industry

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a6623a/chile_pharmaceutic) has announced the addition of the "Chile Pharmaceuticals and Healthcare Report Q3 2008" report to their offering.

Latest forecast sees the Chilean pharmaceutical market growing by a robust 14.8% in US dollar terms in 2008 and by 9.2% in local currency terms. Applying our improved forecasting model, we now see average annual growth rates for 2008 to 2012 of 7.4% in US dollar terms and 6.9% in peso terms, with the total value of the pharmaceutical market, including retail and institutional sectors reaching US$1.84bn by 2012 in final consumer prices, representing a doubling of market value since 2006. The administration of President Michelle Bachelet has bet much of its credibility on expanding healthcare coverage. Increased state spending and broader economic growth should continue to buoy the market, despite ongoing obstacles to market entry for research-based pharmaceutical manufacturers.

A strike by healthcare workers and miners in April over working conditions and action by truckers in June underlined wider discontent and pressure on the government to increase spending. A drought led to further spikes in energy prices as hydroelectric output fell sharply over the first three months of the year. Whatever the challenges facing the current government, Chile remains a relative oasis of clean governance, stability and economic openness and has ratified Free-Trade Agreement (FTA) with the US. Nonetheless, for the research-based pharmaceutical industry, the intellectual property (IP) environment remains deficient.

Key Topics Covered:

Executive Summary

Chile Pharmaceuticals And Healthcare Industry SWOT

Chile Political SWOT

Chile Economic SWOT

Chile Business Environment SWOT

Pharmaceutical Business Environment Ratings

Limits Of Potential Returns

Risks To Realisation Of Returns

Chile – Market Summary

Regulatory Regime

Intellectual Property

Pricing And Reimbursement Issues

Industry Developments

Healthcare Sector

Other Healthcare Developments

Pharmaceutical Sector

Medical Devices

Industry Forecast Scenario

Key Growth Factors – Industry

Key Growth Factors – Macroeconomic

Prescription Market Forecast

OTC Market Forecast

Export/Import Forecast

Key Risks To BMI’s Forecast Scenario

Competitive Landscape

Manufacturing Sector

Retail Sector

Company Monitor

Laboratorios Chile (LabChile)

Laboratorios Andrómaco

Laboratorios Maver

BMI Forecast Modelling

How We Generate Our Pharmaceutical Industry Forecasts

Pharmaceutical Industry

Pharmaceutical Business Environment Ratings Methodology

Ratings Overview

Weighting

Sources

For more information visit http://www.researchandmarkets.com/research/a6623a/chile_pharmaceutic.